216 related articles for article (PubMed ID: 38626188)
1. The elimination of human African trypanosomiasis: Monitoring progress towards the 2021-2030 WHO road map targets.
Franco JR; Priotto G; Paone M; Cecchi G; Ebeja AK; Simarro PP; Sankara D; Metwally SBA; Argaw DD
PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012111. PubMed ID: 38626188
[TBL] [Abstract][Full Text] [Related]
2. The elimination of human African trypanosomiasis: Achievements in relation to WHO road map targets for 2020.
Franco JR; Cecchi G; Paone M; Diarra A; Grout L; Kadima Ebeja A; Simarro PP; Zhao W; Argaw D
PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010047. PubMed ID: 35041668
[TBL] [Abstract][Full Text] [Related]
3. Monitoring the elimination of human African trypanosomiasis: Update to 2016.
Franco JR; Cecchi G; Priotto G; Paone M; Diarra A; Grout L; Simarro PP; Zhao W; Argaw D
PLoS Negl Trop Dis; 2018 Dec; 12(12):e0006890. PubMed ID: 30521525
[TBL] [Abstract][Full Text] [Related]
4. Monitoring the elimination of human African trypanosomiasis at continental and country level: Update to 2018.
Franco JR; Cecchi G; Priotto G; Paone M; Diarra A; Grout L; Simarro PP; Zhao W; Argaw D
PLoS Negl Trop Dis; 2020 May; 14(5):e0008261. PubMed ID: 32437391
[TBL] [Abstract][Full Text] [Related]
5. Control and surveillance of human African trypanosomiasis.
World Health Organization
World Health Organ Tech Rep Ser; 2013; (984):1-237. PubMed ID: 24552089
[TBL] [Abstract][Full Text] [Related]
6. Monitoring the Progress towards the Elimination of Gambiense Human African Trypanosomiasis.
Simarro PP; Cecchi G; Franco JR; Paone M; Diarra A; Priotto G; Mattioli RC; Jannin JG
PLoS Negl Trop Dis; 2015; 9(6):e0003785. PubMed ID: 26056823
[TBL] [Abstract][Full Text] [Related]
7. The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases.
Simarro PP; Cecchi G; Paone M; Franco JR; Diarra A; Ruiz JA; Fèvre EM; Courtin F; Mattioli RC; Jannin JG
Int J Health Geogr; 2010 Nov; 9():57. PubMed ID: 21040555
[TBL] [Abstract][Full Text] [Related]
8. Priorities for the elimination of sleeping sickness.
Welburn SC; Maudlin I
Adv Parasitol; 2012; 79():299-337. PubMed ID: 22726645
[TBL] [Abstract][Full Text] [Related]
9. Do Cryptic Reservoirs Threaten Gambiense-Sleeping Sickness Elimination?
; Büscher P; Bart JM; Boelaert M; Bucheton B; Cecchi G; Chitnis N; Courtin D; Figueiredo LM; Franco JR; Grébaut P; Hasker E; Ilboudo H; Jamonneau V; Koffi M; Lejon V; MacLeod A; Masumu J; Matovu E; Mattioli R; Noyes H; Picado A; Rock KS; Rotureau B; Simo G; Thévenon S; Trindade S; Truc P; Van Reet N
Trends Parasitol; 2018 Mar; 34(3):197-207. PubMed ID: 29396200
[TBL] [Abstract][Full Text] [Related]
10. The journey towards elimination of gambiense human African trypanosomiasis: not far, nor easy.
Franco JR; Simarro PP; Diarra A; Ruiz-Postigo JA; Jannin JG
Parasitology; 2014 May; 141(6):748-60. PubMed ID: 24709291
[TBL] [Abstract][Full Text] [Related]
11. Contemporary and emerging strategies for eliminating human African trypanosomiasis due to Trypanosoma brucei gambiense: review.
Steinmann P; Stone CM; Sutherland CS; Tanner M; Tediosi F
Trop Med Int Health; 2015 Jun; 20(6):707-18. PubMed ID: 25694261
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing passive surveillance for T. b. rhodesiense human african trypanosomiasis in Uganda.
Acup C; Bardosh KL; Picozzi K; Waiswa C; Welburn SC
Acta Trop; 2017 Jan; 165():230-239. PubMed ID: 27212706
[TBL] [Abstract][Full Text] [Related]
13. Monitoring the elimination of human African trypanosomiasis: Update to 2014.
Franco JR; Cecchi G; Priotto G; Paone M; Diarra A; Grout L; Mattioli RC; Argaw D
PLoS Negl Trop Dis; 2017 May; 11(5):e0005585. PubMed ID: 28531222
[TBL] [Abstract][Full Text] [Related]
14. Human African trypanosomiasis: an emerging public health crisis.
Smith DH; Pepin J; Stich AH
Br Med Bull; 1998; 54(2):341-55. PubMed ID: 9830201
[TBL] [Abstract][Full Text] [Related]
15. Determinants of Human African Trypanosomiasis Elimination via Paratransgenesis.
Gilbert JA; Medlock J; Townsend JP; Aksoy S; Ndeffo Mbah M; Galvani AP
PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004465. PubMed ID: 26954675
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis.
Kennedy PGE; Rodgers J
Front Immunol; 2019; 10():39. PubMed ID: 30740102
[TBL] [Abstract][Full Text] [Related]
17. Immune trypanolysis test as a promising bioassay to monitor the elimination of gambiense human African trypanosomiasis.
Dama E; Camara O; Kaba D; Koffi M; Camara M; Compaoré C; Ilboudo H; Courtin F; Kaboré J; N'Gouan EK; Büscher P; Lejon V; Bucheton B; Jamonneau V
Parasite; 2019; 26():68. PubMed ID: 31755862
[TBL] [Abstract][Full Text] [Related]
18. Mapping the capacities of fixed health facilities to cover people at risk of gambiense human African trypanosomiasis.
Simarro PP; Cecchi G; Franco JR; Paone M; Diarra A; Ruiz-Postigo JA; Mattioli RC; Jannin JG
Int J Health Geogr; 2014 Feb; 13():4. PubMed ID: 24517513
[TBL] [Abstract][Full Text] [Related]
19. Human African trypanosomiasis.
Büscher P; Cecchi G; Jamonneau V; Priotto G
Lancet; 2017 Nov; 390(10110):2397-2409. PubMed ID: 28673422
[TBL] [Abstract][Full Text] [Related]
20. Human African trypanosomiasis control: Achievements and challenges.
Aksoy S; Buscher P; Lehane M; Solano P; Van Den Abbeele J
PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005454. PubMed ID: 28426685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
